Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03982043 · ClinicalTrials.gov registry record · NA

Text2Connect, Component 2 of iCHART (Integrated Care to Help At-Risk Teens)

A NA study of Depression and Suicidal Ideation, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
47
Enrollment target
4
Study locations

NCT03982043 is a NA study of Depression and Suicidal Ideation that has completed, run by University of Pittsburgh. The registered enrollment target is 47 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03982043, a NA study of Depression and Suicidal Ideation, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
4
Study locations

Study Summary

This study proposes to develop and examine a personalized, text-based intervention designed to improve engagement with mental health (MH) treatment.

Interventions

  • BEHAVIORAL Text2Connect

Study Locations (4)

Pennsylvania

  • CCP Waterdam - McMurray
  • Children's Community Pediatrics (CCP-Natrona Heights) of Children's Hospital of Pittsburgh of UPMC - Natrona Heights
  • Children's Community Pediatrics (CCP-GIL) of Children's Hospital of Pittsburgh of UPMC - Pittsburgh
  • STAR-Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2019-05-28
Est. Completion 2020-06-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT03982043

The ClinicalTrials.gov registry entry for NCT03982043 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Text2Connect is the first listed.

NCT03982043 reports 4 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03982043 about?

NCT03982043 is a clinical study titled "Text2Connect, Component 2 of iCHART (Integrated Care to Help At-Risk Teens)". This study proposes to develop and examine a personalized, text-based intervention designed to improve engagement with mental health (MH) treatment.

What is the current status of trial NCT03982043?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2019-05-28. Estimated completion is 2020-06-30.

What conditions does trial NCT03982043 study?

This clinical trial studies the following conditions: Depression, Suicidal Ideation.

What interventions are being tested in trial NCT03982043?

The interventions under investigation include: Text2Connect (BEHAVIORAL).

Who is sponsoring clinical trial NCT03982043?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03982043 being conducted?

This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.